Acerus Pharma - Company & Market Research Reports

Founded in 2008, Acerus Pharmaceuticals focuses on the therapeutic areas of Men’s Health (Urology) and Women’s Health (Hormone Replacement Therapy, Female Sexual Dysfunction). It has developed products for male hypogonadism, women’s hormone replacement therapy, and female sexual dysfunction. The company’s approved products include Natesto, a bioadhesive intranasal gel formulation of testosterone; and Estrace, an oral tablet for the symptomatic relief of menopausal symptoms. Acerus is headquartered in Mississauga, Canada.

From
From
From
From
From
Male Hypogonadism - Pipeline Review, H2 2018 - Product Thumbnail Image

Male Hypogonadism - Pipeline Review, H2 2018

  • Drug Pipelines
  • 101 Pages
From
From
From
From
Acerus Pharmaceuticals Corporation - Product Thumbnail Image

Acerus Pharmaceuticals Corporation

  • Company Profile
  • 75 Pages
Loading Indicator
adroll